Rapid advancements in biotechnologies such as wearable sensors, –omic (genomics, proteomics, metabolomics, lipidomics etc.), next generation sequencing, bio-nanotechnologies, and molecular imaging etc. accelerate the data explosion in biomedicine and health wellness. Multiple nations around the world have been seeking novel effective ways to make sense of “big data” with AI for evidence-based, outcome-driven, and affordable 5P (Patient-centric, Predictive, Preventive, Personalized, and Precise) health care. The goal is develop multi-modal and multi-scale (i.e. molecular, cellular, whole body, individual, and population) biomedical data analysis with AI for discovery, development, and delivery. Ultimately, the goal is to promote healthy aging, improve quality of patient care, and reduce healthcare cost. However, during the COVID-19 pandemic, many AI tools have been developed, but a few have shown true impact. First, I will discuss a recent MIT Technology Review on AI tools impact in combating COVID-19 pandemics. Second, I will provide a systematic review regarding the causes. Next, I will present opportunities in harnessing data by using HL7 Fast Health Informatics Resource (FHIR) to integrate genomics, imaging, physiological, and clinical EMR for improving 5P health. Then I will highlight the progresses made and opportunities in improving data quality. Also, I will share what needs to be done to make multi-modality data analysis outcome usable by clinicians. Last, I will present an emerging intelligent reality to increase impact of AI and BHI in post-pandemic era.
Dr. Wang is a Wallace H. Coulter Distinguished Faculty Fellow and a full professor in the Departments of Biomedical Eng. and Electrical and Computer Eng. at Georgia Institute of Technology and Emory University. Her research is in Biomedical Big Data Analytics with a focus on Biomedical and Health Informatics (BHI) and Artificial Intelligence (AI) for predictive, personalized, and precision health (pHealth). She published over 260 peer-reviewed articles in referred journals and conference proceedings with Google Scholar citations of over 12,800+ times, and delivered over 240 invited and keynote lectures. Dr. Wang is the Director of Biomedical Big Data Initiative, a Kavli Fellow, a Georgia Distinguished Cancer Scholar, a Petit Institute Faculty Fellow, an AIMBE Fellow, an IAMBE Fellow, and a member of Board of Directors in American Board of AI in Medicine. Dr. Wang received BEng from Tsinghua University China, and MSCS, and PhD EE degrees from Georgia Institute of Technology. She is a recipient of Georgia Tech Outstanding Faculty Mentor Award for Undergraduate Research, and a recipient of Emory University MilliPub Award (for a high-impact paper that is cited over 1,000 times). Dr. Wang currently serves as the Senior Editor for IEEE Journal of Biomedical and Health Informatics, an Associate Editor for both IEEE Transactions for BME and IEEE Reviews for BME, a standing panelist for NIH CDMA study section, a multi-year NSF Smart and Connect Health panelist, and a panelist for Brain Canada and multiple European countries. She has been helping grow the large bioinformatics and health informatics technical communities in IEEE EMBS, ACM, and Gordon Research Conferences. In 2021, Dr. Wang is a member of Georgia Tech Provost’s Emerging Leader’s Program and is elected into IAMBE Executive Committee. She is currently Chair of Biomedical and Health Informatics Technical Community/Committee, and chair of ACM Special Interest Group in Bioinformatics. During 2018-2020, Dr. Wang was Carol Ann and David Flanagan Distinguished Faculty Fellow at Georgia Tech. During 2017-2019, she served as Vice President of IEEE EMBS and AIMBE Bioinformatics Nomination Committee Chair. During 2015-2018, she was Georgia Tech Biomedical Informatics Program Co-Director in Atlanta Clinical and Translational Science Institute (ACTSI). During 2015-2016, she was IEEE Engineering in Medicine and Biology Society (EMBS) Distinguished Lecturer and an Emerging Area Editor for PNAS. Before 2016, Dr. Wang was Director of Bioinformatics and Biocomputing Core in NIH/NCI-sponsored U54 Center for Cancer Nanotechology Excellence, and Co-Director of Georgia-Tech Center of Bio-Imaging Mass Spectrometry for over 10 years. Dr. Wang’s research has been supported by NIH, NSF, CDC, Georgia Research Alliance, Georgia Cancer Coalition, Shriners’ Hospitals for Children, Children’s Health Care of Atlanta, Enduring Heart Foundation, Coulter Foundation, Microsoft Research, HP, UCB, and Amazon.